The Late Presenter Treatment Optimisation Study

NCT03696160 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

447

Enrollment

OTHER

Sponsor class

Conditions

HIV/AIDS

Interventions

DRUG: Biktarvy
DRUG: Symtuza

Sponsor

NEAT ID Foundation

Collaborators

[object Object]
[object Object]